ANNUAL REPORT FOR FY 2025-26

BRAWN BIOTECH LTD. September 01, 2026 The Deputy General Manager, Department of Corporate Relationship BSE Limited, P.J. Towers Dalal Street, Mumbai - 400001 Scrip Code: 530207 Sub: Annual Report 2025-26 and the Notice of 41st Annual General Meeting Dear Sir, Pursuant to Regulation 30 & 34 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (i.e. LODR Regulations), please find enclosed the Annual Report for FY 2025-26 along with Notice for the 41% Annual General Meeting of the company scheduled to be held on 29™ September 2026 through VC/OAVM, The Annual Report and the Notice of 41% AGM is available on the Company’s website at The information about key events for the 41 AGM and Remote E-voting is as follows: Event Timelines Cut-off date for e-voting Tuesday, 22 September 2026 E-voting start date Saturday, 26 September 2026 at 09:00 A.M. IST E-voting end date Monday, 28 September 2026 at 05:00 P.M. IST Annual General Meeting Tuesday, 29 September 2026 at 11.00 A.M. IST This is for your information and record. Thanking you. For and on behalf of Brawn Biotech LimitedJ Priyanka Sharma Company Secretary & Compliance Officer Encl: As above ‘ CIN NO.: L74899DL1985PLC022468 . fon betten life Regd. Office : C-64, Lajpat Nagar-1, First Floor, New Delhi-110024, INDIA Tel.: 011-29815331 ' Email: solution@brawnbiotech.com Works : Plot No.44, Pace City-1, Sector 37, Near Hero Honda Chowk, Gurugram - 122001, Haryana, INDIA BRAWN BIOTECH LTD. Email: distribution@brawnlabs.in | Website : www.brawngroup.in 41st Annual Report 2025-2026 Brawn Biotech Limited Formerly known as Brawn Pharmaceuticals Limited BRAWN BIOTECH LIMITED CIN: L74899DL1985PLC022468 | www.brawnbiotech.com Regd Office: C-64, First Floor, Lajpat Nagar-1, Delhi-110024 CORPORATE INFORMATION Name of the Company Brawn Biotech Limited Corporate Identity No. (CIN) L74899DL1985PLC022468 Board of Directors Mr. Brij Raj Gupta, Director Mr. Mayank Jain, Independent Director Ms. Pooja Jha, Independent Director Chief Financial Officer (KMP) Ms. Rati Garg Company Secretary & Compliance Officer Ms. Priyanka Sharma (KMP) Manager (KMP) Mr. Amit Kumar Share Registrars RCMC Share Registry Pvt Ltd B-25/1, 1st Floor, Okhla Industrial Area Phase II, New Delhi, 110020. Tel.: +91-11-26387320880 Email: investor.services@rcmcdelhi.com Website: www.rcmcdelhi.com Statutory Auditors Rajiv Udai & Associates, Chartered Accountants Registered Office First Floor, C-64 Lajpat Nagar-1, Delhi, 110024 Email: solution@brawnbiotech.com Investor relations: solution@brawnbiotech.com Website: www.brawnbiotech.com Tel: 01129815331 BRAWN BIOTECH LIMITED CIN: L74899DL1985PLC022468 | www.brawnbiotech.com Regd Office: C-64, First Floor, Lajpat Nagar-1, Delhi-110024 Contents Page no. Notice and Explanatory Statement 4-15 Directors’ Report 16-25 Annexures to Directors’ Report 26-35 Financial Statements Auditors’ Report 36-38 Annexure to the Auditors’ Report 39-42 Balance Sheet 43 Statement of Profit and Loss 44-45 Cash Flow Statement 46-47 Notes forming part of the Financial Statements 48-68 BRAWN BIOTECH LIMITED CIN: L74899DL1985PLC022468 | www.brawnbiotech.com Regd Office: C-64, First Floor, Lajpat Nagar-1, Delhi-110024 41st Annual General Meeting NOTICE The FORTY FIRST ANNUAL GENERAL MEETING of BRAWN BIOTECH LIMITED will be held on Tuesday, 29th day of September 2026 at 11.00 a.m. IST through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”) to transact the following business: ORDINARY BUSINESS: 1. To receive, consider and adopt the Audited Financial Statements for the financial year ended 31st March 2026 together with the Reports of the Board of Directors and the Auditors thereon. 2. To appoint a director in place of Mr. Brij Raj Gupta (DIN: 00974969) who retires by rotation and being eligible, offers himself for re-appointment. 3. Appointment of M/s. G D S M and Co. Chartered Accountants (Firm Registration No. 034194N) as the Statutory Auditors of the Company. SPECIAL BUSINESS: 1. To consider and approve managerial remuneration of Mr. Amit Kumar (Manager-KMP) as per the provisions of Companies Act, 2013. To consider and, if thought fit, to pass with or without modification, the following Resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to Sections 196, 197, 198 and 203 read with Schedule V of the Companies Act, 2013, and pursuant to the recommendation of Nomination & Remuneration Committee and subsequent approval of the Board of Directors of the Company, the consent of the members be and is hereby accorded to the payment of remuneration of ₹9,76,512/- (Rupees Nine Lakh Seventy-Six Thousand Five Hundred and Twelve only) per annum, to Mr. Amit Kumar, Manager of the Company, for a period of three years effective from 12.02.2026, forming part of and without prejudice to his said overall five-year term of appointment. RESOLVED FURTHER THAT notwithstanding to the above, in the event of loss or inadequacy of profits in any financial year of the Company during period of three years, the remuneration payable to Mr. Amit Kumar as Manager (KMP) of the Company shall be in accordance and within the limits prescribed in Schedule V read with Section 197 of the Companies Act, 2013, as amended from time to time subject to the compliance of provisions thereof. RESOLVED FURTHER THAT any Director and/or Company Secretary of the Company be and is hereby authorised to do all such acts, deeds, matters and things as may be necessary, expedient or incidental to give effect to this resolution.” By Order of the Board of Directors Sd/- Priyanka Sharma Company Secretary & Compliance Officer Place: Delhi, Date: August 13, 2026 BRAWN BIOTECH LIMITED CIN: L74899DL1985PLC022468 | www.brawnbiotech.com Regd Office: C-64, First Floor, Lajpat Nagar-1, Delhi-110024 NOTES: 1. The Explanatory statement setting out the material facts pursuant to Section 102 of the Companies Act concerning the Special Business in the Notice is annexed hereto and forms part of this Notice. 2. The Ministry of Corporate Affairs ("MCA"), inter alia, vide its General Circular No. 14/2020 dated April 8, 2020, General Circular No. 17/2020 dated April 13, 2020, General Circular No. 20/2020 dated May 5, 2020, and subsequent circulars issued in this regard, the latest being General Circular No. 03/2025 dated September 22, 2025 (collectively referred to as the "MCA Circulars"), has permitted the holding of the Annual General Meeting ("AGM") through Video Conferencing ("VC") or Other Audio-Visual Means ("OAVM"), till further orders, in accordance with the requirements laid down in Paragraphs 3 and 4 of General Circular No. 20/2020 dated May 5, 2020, without the physical presence of the Members at a common venue. In compliance with the provisions of the Companies Act, 2013 ("the Act"), the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), the MCA Circulars and the SEBI Circulars, the 41st Annual General Meeting ("Meeting" or "AGM") of the Company is scheduled to be held through VC/OAVM on Tuesday, September 29, 2026, at 11.00 A.M. (IST). The proceedings of the AGM shall be deemed to be conducted at the Registered Office of the Company situated at C-64, First Floor, Lajpat Nagar-1, Delhi- 110024. 3. Pursuant to the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 (as amended) and Regulation 44 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (as amended), and MCA Circulars dated April 08, 2020, April 13, 2020 and May 05, 2020 the Company is providing facility of remote e-voting to its Members in respect of the business to be transacted at the AGM/EGM. For this purpose, the Company has entered into an agreement with Central Depository Services (India) Limited (CDSL) for facilitating voting through electronic means, as the authorized e-Voting’s agency. The facility of casting votes by a [Showing first 8,000 characters — download PDF for full document]